Table 3.
Comparisons of material features and research status of BDBS stents.
| Material category | Features | Research status | Degradation time | References |
|---|---|---|---|---|
| PDX | Commonly used, good flexibility, low mechanical strength | Human (in vivo) | 3–6 months | (82, 106) |
| PLA | Good mechanical properties, adjustable degradation time, self-cleaning | Pigs, dogs, in vitro (bile) | >9 months | (1, 94, 95) |
| PCL | Good biocompatibility, drug-controlled release, low melting point | Pigs, in vitro (bile) | 3 months | (96, 97, 102, 104) |
| PGA | Good biocompatibility, fast degradation | Pigs | 2 months | (106, 108) |
| PLGA | Fast but adjustable degradation | In vitro (bile) | 2–3 weeks | (90) |
| PTMC | Average mechanical strength, adjustable degradation time | Rats, in vitro | 10–14 weeks | (109, 110) |
| Magnesium alloy | Widely used, safety, adjustable degradation speed, can inhibit the development of biliary tumors | Rabbits | 20 weeks | (115–117) |
PDX, polydioxanone; PLA, polylactic acid; PCL, polycaprolactone; PGA, polyglycolic acid; PLGA, poly(lactic-co-glycolic acid); PTMC, poly (trimethylene carbonate).